juvenile myelomonocytic leukaemia

(redirected from JMML)
Also found in: Acronyms.

juvenile myelomonocytic leukaemia

A paediatric myelodysplastic syndrome (OMIM:607785) which comprises approximately 30% of childhood cases of myelodysplastic syndrome and 2% of leukaemia.

Molecular pathology
Germline mutations of NF1 account for the association of JMML with type-1 neurofibromatosis.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
References in periodicals archive ?
JMML accounts for 1% to 2% of childhood leukaemias each year.
Money from the Wish campaign will be added to the pounds 26,000 already raised by the Charlotte Wren Forget-Me-Not Fund to pay for research into JMML and to sponsor a room in Charlotte's name at Crawford House, which provides free accommodation for local families who have to travel to Newcastle to receive medical treatment for children with life-threatening illnesses.
The fund aims to raise money for vital research into JMML; sponsor a room in Charlotte's name, providing free accommodation through the sick children's trust for any local families facing life threatening illnesses who have to travel to Newcastle away from their own homes to receive vital life giving treatment for their child; match our current fund raising events with a potential target of pounds 10,000.
Generous Gazette readers have sent in donations ranging from pounds 10 to pounds 150 for the fund, raising money for research into JMML.
All funds raised will be channelled into JMML research and an annual donation will go to Crawford House in Newcastle, which provided her family with a home while she had treatment at the Royal Victoria Infirmary.
Juvenile myelomonocytic leukemia (JMML) patients harbor also clonal cytogenetic abnormalities.
Patient 1 is a 6-year-old originally diagnosed with Franconi anemia transformed JMML and eventually to AML-M5 with more than 90% blasts in the marrow, complex karyotype and FLT3-ITD mutation.
Zarqa was diagnosed with juvenile myelomonocytic leukemia (JMML), a rare childhood cancer.
On the other hand, myriad hematopoietic diseases, for example, juvenile myelomonocytic leukemia (JMML), are closely associated with dysfunction of SHP2 in HSCs.
PTPN11 pathogenic variants have been found in approximately 50% cases with NS and are also frequently positively associated with familial inheritance, pulmonary stenosis, ASD, HCM, short stature, sternal deformity, bleeding diathesis, juvenile myelomonocytic leukemia (JMML), and NS/MPD [3, 6, 10].
In May, Noah was diagnosed with juvenile myelomonocytic leukaemia (JMML) - a form of rare childhood cancer.